Product Program year 2021 Source: CMS Open Payments

Solyx

Device Pelvic Organ Prolapse

PDI 8.71473E+12

Open in the dashboard

General payments

$213

5 payments

Research payments

0 payments

Through program year 2021, $213 in general payments and $0 in research payments were reported against Solyx (Pelvic Organ Prolapse).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row

Year	Kind	Amount	Payments
2021	General	$213	5

Breakdown

Who paid General payments · program year 2021

Boston Scientific Corporation $213 5 payments

Top recipients General payments · program year 2021

Erica Eggers Urogynecology and Reconstructive Pelvic Surgery · Milwaukee, WI $141 66% · 2 payments
Trang Pham Urogynecology and Reconstructive Pelvic Surgery · Wichita, KS $38 18% · 1 payment
Samuel Chacon Reno, NV $35 16% · 2 payments

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021

Urogynecology and Reconstructive Pelvic Surgery Urology $141 79% · 1 practitioner
Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $38 21% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021

Florida $141 66% · 1 recipient
Oklahoma $38 18% · 1 recipient
Nevada $35 16% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

Records

5 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.